Breast cancer - gemcitabine
Gemcitabine for the treatment of metastatic breast cancer
| Guidance type: Technology appraisal |
| Date issued: January 2007 |
We will consult on our review plans for this guidance in January 2010. |
| Reference: TA116 |
SummaryGemcitabine, which is combined with another medicine called paclitaxel to treat metastatic breast cancer, is only recommended as a possible treatment for people with metastatic breast cancer in situations where two other treatments could also be used as alternatives. Other treatments that doctors could use in the same situation are a medicine called docetaxel (given on its own) and docetaxel combined with another medicine called capecitabine. |
| Top |
DocumentsFor healthcare professionals
For patients, carers and the public
Background information
|
Implementing this guidanceAny further information NICE has produced to help the NHS implement this guideline locally is linked to below: |
| Top |
